# Caldan Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caldan-therapeutics

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.caldantherapeutics.com
- Total disclosed funding: $8.7M
- Latest round: Series A (Jun 19, 2019)
- Investors on record: 3

## About

Based in Glasgow, UK, Caldan Therapeutics Ltd, a spin-out from the Universities of Glasgow and Southern Denmark, operates as a biotechnology company that develops novel therapeutics targeting free fatty acid receptors for NASH, Type 2 Diabetes (T2D) and other potential indications.

## Funding rounds

- Series A, Jun 19, 2019, $2.5M — Epidarex Capital, LifeArc
- Series A, Oct 9, 2015, $6.1M — Epidarex Capital, Scottish Enterprise

## Investors

- Epidarex Capital (https://capitalatlas.ai/funds/epidarex-capital) — Series A
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A
- LifeArc (https://capitalatlas.ai/funds/lifearc) — Series A